These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34175948)

  • 1. Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-2018.
    McClung RP; Oster AM; Ocfemia MCB; Saduvala N; Heneine W; Johnson JA; Hernandez AL
    Clin Infect Dis; 2022 Mar; 74(6):1055-1062. PubMed ID: 34175948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between next-generation and Sanger-based sequencing for the detection of transmitted drug-resistance mutations among recently infected HIV-1 patients in Israel, 2000-2014.
    Moscona R; Ram D; Wax M; Bucris E; Levy I; Mendelson E; Mor O
    J Int AIDS Soc; 2017 Aug; 20(1):21846. PubMed ID: 28799325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.
    de Salazar A; Viñuela L; Fuentes A; Teyssou E; Charpentier C; Lambert-Niclot S; Serrano-Conde E; Pingarilho M; Fabeni L; De Monte A; Stefic K; Perno CF; Aguilera A; Falces I; Delgado R; Fernandes S; Diogo I; Gomes P; Paraskevis D; Santoro MM; Ceccherini-Silberstein F; Marcelin AG; Garcia F
    Clin Infect Dis; 2023 May; 76(9):1628-1635. PubMed ID: 36571282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Diversity and Drug Resistance in Treatment-Naïve Children and Adolescents from Rio de Janeiro, Brazil.
    de Azevedo SSD; Delatorre E; Gaido CM; Silva-de-Jesus C; Guimarães ML; Couto-Fernandez JC; Morgado MG
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
    Chen GJ; Cheng CY; Yang CJ; Lee NY; Tang HJ; Huang SH; Huang MH; Liou BH; Lee YC; Lin CY; Hung TC; Lin SP; Sun HY; Chang SY; Hung CC;
    J Antimicrob Chemother; 2024 May; 79(5):1157-1163. PubMed ID: 38546761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017-2020.
    Fiebig U; Altmann B; Hauser A; Koppe U; Hanke K; Gunsenheimer-Bartmeyer B; Bremer V; Baumgarten A; Bannert N
    BMC Infect Dis; 2023 Oct; 23(1):673. PubMed ID: 37817087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Frequency of Integrase Inhibitor Resistance Mutations Among Therapy-Naïve HIV Patients in Southeast China.
    Lai J; Liu Y; Han X; Huang A; Lin J; Ao W; Ye H; Chen Y
    Drug Des Devel Ther; 2021; 15():889-894. PubMed ID: 33679129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort.
    Sarinoglu RC; Sili U; Hasdemir U; Aksu B; Soyletir G; Korten V
    Curr HIV Res; 2022; 20(1):54-62. PubMed ID: 34802406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.
    Hu Z; Kuritzkes DR
    J Virol; 2014 Aug; 88(16):9268-76. PubMed ID: 24899199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full-spectrum HIV drug resistance mutation detection by high-resolution complete pol gene sequencing.
    Faraci G; Park SY; Dubé MP; Lee HY
    J Clin Virol; 2023 Jul; 164():105491. PubMed ID: 37182384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors.
    Andreis S; Basso M; Scaggiante R; Cruciani M; Ferretto R; Manfrin V; Panese S; Rossi MC; Francavilla E; Boldrin C; Alvarez M; Dal Bello F; Mengoli C; Turriziani O; Sarmati L; Antonelli G; Andreoni M; Palù G; Parisi SG
    J Glob Antimicrob Resist; 2017 Sep; 10():106-112. PubMed ID: 28732792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.
    Kagan RM; Dunn KJ; Snell GP; Nettles RE; Kaufman HW
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):698-709. PubMed ID: 31169022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of pretreatment drug resistance mutations in treatment-naïve people living with HIV-1 in Henan Province, China (2022/23).
    Liu J; Liu C; Wang Y; Wei S; Ma J; Li Y; Chen X; Zhao Q; Huo Y
    Infect Genet Evol; 2023 Nov; 115():105520. PubMed ID: 37898414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment HIV-1 Resistance in Argentina: Results from the Second Surveillance Study Following World Health Organization Guidelines (2019).
    Laufer NL; Bouzas MB; Fernández Giuliano S; Zapiola I; Mammana L; Salomon H; Monzani C; Castro G; Suarez Ornani ML; Rojas Machado P; Cochon N; Adazsko A; Ravasi G; Vila M; Maulen S; Ceriotto M; Barbas MG; Martini S
    AIDS Res Hum Retroviruses; 2024 Aug; 40(8):464-470. PubMed ID: 38386507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
    Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC
    Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir.
    Barnas D; Koontz D; Bazmi H; Bixby C; Jemsek J; Mellors JW
    Antivir Ther; 2010; 15(3):437-41. PubMed ID: 20516563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of genotypic resistance to nucleoside analogues, nonnucleoside analogues, and protease inhibitors in HIV-infected persons in Athens, Greece.
    Panos G; Charatsis G; Paparizos V; Kazantzi M; Falagas ME
    AIDS Res Hum Retroviruses; 2008 Jan; 24(1):43-51. PubMed ID: 18275347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010-2018.
    Wagner T; Zuckerman NS; Halperin T; Chemtob D; Levy I; Elbirt D; Shachar E; Olshtain-Pops K; Elinav H; Chowers M; Itsomin V; Riesenberg K; Wax M; Shirazi R; Gozlan Y; Matus N; Girshengorn S; Marom R; Mendelson E; Turner D; Mor O
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses.
    Hauser A; Hofmann A; Meixenberger K; Altmann B; Hanke K; Bremer V; Bartmeyer B; Bannert N
    PLoS One; 2018; 13(11):e0206234. PubMed ID: 30408827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.